Showing results (1571-1580 of 1,799) with videos related to

Sort By:
Pageof 180
The British Journal of Ophthalmology|October 20, 2006
Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachomaJon L Yang, Julius Schachter, Jeanne Moncada, et al.
Journal of Clinical Microbiology|March 4, 2000
Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatisB Van Der Pol, T C Quinn, C A Gaydos, et al.
Plos Neglected Tropical Diseases|December 20, 2011
Risk factors for ocular chlamydia after three mass azithromycin distributionsBerhan Ayele, Teshome Gebre, Jeanne Moncada, et al.
Brain, Behavior, and Immunity|September 11, 2017
Effects of obesity on depression: A role for inflammation and the gut microbiotaJulieta Schachter, Jan Martel, Chuan-Sheng Lin, et al.
Microbes and Infection|December 19, 2017
Plasmodium falciparum invasion and intraerythrocytic development are impaired by 2', 3'-dialdehyde adenosineLeandro S Silva, Gustavo C Prado, Paula G Quintana, et al.
Ophthalmology|September 12, 2009
Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributionsJesse B Biebesheimer, Jenafir House, Kevin Cyrus Hong, et al.
American Journal of Public Health|October 28, 2021
Cross-Sector Monitoring and Evaluation Framework: Social, Economic, and Health Conditions Impacted During the COVID-19 PandemicEva Y Wong, Abigail Schachter, Hannah N Collins, et al.
EGEMS (Washington, DC)|April 8, 2015
Data governance and data sharing agreements for community-wide health information exchange: lessons from the beacon communitiesClaudia Allen, Terrisca R Des Jardins, Arvela Heider, et al.
Plos One|March 2, 2013
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaOrit Itzhaki, Eyal Greenberg, Bruria Shalmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-overR Paridaens, L Biganzoli, P Bruning, et al.
Pageof 180